Interagency Workgroup on Implementation DAT Act of 2000

AttachmentC.wpd

Notification of Intent to Use Schedule III, IV, or V Opioid Drugs for the Maintenance and Detoxification Treatment of Opiate Addiction

Interagency Workgroup on Implementation DAT Act of 2000

OMB: 0930-0234

Document [pdf]
Download: pdf | pdf

ATTACHMENT C

Interagency Workgroup on Implementation of

the Drug Addiction Treatment Act of 2000


Substance Abuse and Mental Health Services Administration

Joe Faha, Office of Policy and Legislation

301-443-7017

Steve Wing, Office of Policy

301-443-0593

Center for Substance Abuse Treatment

H.Westley Clark, MD, Director

301-443-5700

Sheila Harmison, Special Assistant

301-443-7524

George Kanuck, Office of Policy

301-443-8642

Susanne Caviness, Office of Pharm. And Alt. Therapies

301-443-7614

Robert Lubran, Office of Pharm. And Alt. Therapies

301-443-7745

Alan Trachtenberg, MD, Office of Pharm. And Alt. Therapies

301-443-1281

Nick Reuter, Office of Pharm. And Alt. Therapies

301-443-0457

Food and Drug Administration

Celia Winchel, MD, Medical Officer, DACCP

301-827-7410

Jarilyn Dupont, Office of Legislative Affairs

301-827-0110

Public Health Service Office of General Counsel

Elizabeth Sainden, Regulatory Counsel

301-443-8376

Department of Health and Human Services

Tom Vischi, Office of Science and Public Health

202-260-3601

National Institute on Drug Abuse

Joel Egertson, Senior Advisor

301-435-8782

Drug Enforcement Administration

Ann Hensler, Office of Liaison and Policy

202-353-7098

Office of Veterans Affairs

Richard Suchinsky, M.D.

202-273-8437

George Woody, MD, Philadelphia VA Hospital

225-399-0980

Office of National Drug Control Policy

Barbara Roberts, Ph.D, Office of Demand Reduction

202-395-6601


File Typeapplication/octet-stream
File Modified0000-00-00
File Created0000-00-00

© 2024 OMB.report | Privacy Policy